Comera Life Sciences Holdings, Inc. (CMRA)

USD 0.0

(-50.0%)

Total Assets Summary of Comera Life Sciences Holdings, Inc.

  • Comera Life Sciences Holdings, Inc.'s latest annual total assets in 2022 was 3.72 Million USD , down -49.75% from previous year.
  • Comera Life Sciences Holdings, Inc.'s latest quarterly total assets in 2023 Q2 was 2.34 Million USD , down -21.97% from previous quarter.
  • Comera Life Sciences Holdings, Inc. reported annual total assets of 7.41 Million USD in 2021, up 1258.88% from previous year.
  • Comera Life Sciences Holdings, Inc. reported annual total assets of 545.87 Thousand USD in 2020, down 0.0% from previous year.
  • Comera Life Sciences Holdings, Inc. reported quarterly total assets of 2.99 Million USD for 2023 Q1, down -19.53% from previous quarter.
  • Comera Life Sciences Holdings, Inc. reported quarterly total assets of 3.07 Million USD for 2023 Q3, up 31.27% from previous quarter.

Annual Total Assets Chart of Comera Life Sciences Holdings, Inc. (2022 - 2020)

Historical Annual Total Assets of Comera Life Sciences Holdings, Inc. (2022 - 2020)

Year Total Assets Total Assets Growth
2022 3.72 Million USD -49.75%
2021 7.41 Million USD 1258.88%
2020 545.87 Thousand USD 0.0%

Peer Total Assets Comparison of Comera Life Sciences Holdings, Inc.

Name Total Assets Total Assets Difference
America Great Health 299.12 Thousand USD -1145.989%
Ampio Pharmaceuticals, Inc. 5.73 Million USD 35.022%
Aridis Pharmaceuticals, Inc. 14.69 Million USD 74.637%
Biora Therapeutics, Inc. 31.21 Million USD 88.06%
Bio-Path Holdings, Inc. 3.22 Million USD -15.749%
Better Therapeutics, Inc. 22.94 Million USD 83.755%
Calithera Biosciences, Inc. 28.67 Million USD 87.003%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 20.54 Million USD 81.858%
Eloxx Pharmaceuticals, Inc. 21.12 Million USD 82.355%
Evelo Biosciences, Inc. 64.44 Million USD 94.216%
Evolutionary Genomics, Inc. 2.35 Million USD -58.351%
Finch Therapeutics Group, Inc. 70.99 Million USD 94.75%
Galera Therapeutics, Inc. 26.14 Million USD 85.742%
Innovation1 Biotech Inc. 75.99 Thousand USD -4804.548%
Kiromic BioPharma, Inc. 12.16 Million USD 69.372%
Molecular Templates, Inc. 35.38 Million USD 89.466%
Navidea Biopharmaceuticals, Inc. 4.37 Million USD 14.743%
NexImmune, Inc. 8.59 Million USD 56.631%
Orgenesis Inc. 14.55 Million USD 74.388%
Panbela Therapeutics, Inc. 11.8 Million USD 68.42%
Point of Care Nano-Technology, Inc. 124.64 Thousand USD -2890.23%
PaxMedica, Inc. Common Stock 5.68 Million USD 34.386%
Scopus BioPharma Inc. 392.26 Thousand USD -850.152%
Sorrento Therapeutics, Inc. 472.84 Million USD 99.212%
Statera Biopharma, Inc. 21.16 Million USD 82.394%
TRACON Pharmaceuticals, Inc. 10.1 Million USD 63.116%
Trevena, Inc. 40.6 Million USD 90.821%
Vaxxinity, Inc. 44.35 Million USD 91.597%
Vaccinex, Inc. 3.63 Million USD -2.647%
Vicapsys Life Sciences, Inc. 39.65 Thousand USD -9298.611%
Viracta Therapeutics, Inc. 56.69 Million USD 93.426%
ZIVO Bioscience, Inc. 555.71 Thousand USD -570.688%